Merck & Co. (NYSE: MRK), known as MSD outside the United States and Canada, is a multinational pharmaceutical company that researches, develops, and markets prescription medicines, vaccines, and animal health products. Its portfolio spans oncology (including its flagship immunotherapy franchise), vaccines, cardiometabolic and infectious disease treatments, and a sizeable veterinary segment.
MarketMoodIQ tracks MRK because large-cap pharma is a defensive anchor in US equity flows, and rotations into or out of healthcare often coincide with shifts in broader risk appetite that also show up across crypto and growth assets.
LunarCrush has no topic stream for MRK, so mood, sentiment, and social-volume cards aren't shown — price, market cap, and 24h change come from the equity feed and are accurate.
Research only — not financial advice.